| 452 | A | 200913 | 002 | CHOLINE FENOFIBRATE | CAPSULE, DELAYED RELEASE;ORAL | CAPSULE, DELAYED RELEASE | ORAL | FENOFIBRIC ACID | MYLAN PHARMS INC | EQ 135MG FENOFIBRIC ACID | | [] | 2013-03-25 | Mar 25, 2013 | No | No | No | DISCN | MYLAN PHARMACEUTICALS INC | 3ef4363808eea75781cfd8c83bcb281fe3d799fa0423411fcbe734c8656879ed |
| 453 | A | 210469 | 001 | CHOLINE FENOFIBRATE | CAPSULE, DELAYED RELEASE;ORAL | CAPSULE, DELAYED RELEASE | ORAL | FENOFIBRIC ACID | TWI PHARMS | EQ 45MG FENOFIBRIC ACID | AB | ["AB"] | 2019-07-05 | Jul 5, 2019 | No | No | No | RX | TWI PHARMACEUTICALS INC | f9d2caafa62c4f24609cb8c0abc3f094251c63a971d61e0353d30c5cfcffbbf7 |
| 454 | A | 210469 | 002 | CHOLINE FENOFIBRATE | CAPSULE, DELAYED RELEASE;ORAL | CAPSULE, DELAYED RELEASE | ORAL | FENOFIBRIC ACID | TWI PHARMS | EQ 135MG FENOFIBRIC ACID | AB | ["AB"] | 2019-07-05 | Jul 5, 2019 | No | No | No | RX | TWI PHARMACEUTICALS INC | d908210eb3bea5cf9501418c420af7d72f51d67066a4f5998a9db00e79a4bdd7 |
| 455 | A | 212562 | 001 | CHOLINE FENOFIBRATE | CAPSULE, DELAYED RELEASE;ORAL | CAPSULE, DELAYED RELEASE | ORAL | FENOFIBRIC ACID | YICHANG HUMANWELL | EQ 45MG FENOFIBRIC ACID | AB | ["AB"] | 2020-12-23 | Dec 23, 2020 | No | No | No | RX | YICHANG HUMANWELL PHARMACEUTICAL CO LTD | 4f418e19a1cea4549a30be8aab0e3fd2936de5c9d08d6d42475d6645bc354905 |
| 456 | A | 212562 | 002 | CHOLINE FENOFIBRATE | CAPSULE, DELAYED RELEASE;ORAL | CAPSULE, DELAYED RELEASE | ORAL | FENOFIBRIC ACID | YICHANG HUMANWELL | EQ 135MG FENOFIBRIC ACID | AB | ["AB"] | 2020-12-23 | Dec 23, 2020 | No | No | No | RX | YICHANG HUMANWELL PHARMACEUTICAL CO LTD | 0f9e5d60e88c974ab0459c2f43869b2fb4f2934d67cad01c463d3a0afa90462e |
| 457 | A | 207873 | 001 | MESALAMINE | CAPSULE, DELAYED RELEASE;ORAL | CAPSULE, DELAYED RELEASE | ORAL | MESALAMINE | TEVA PHARMS USA | 400MG | AB | ["AB"] | 2019-05-09 | May 9, 2019 | No | No | No | RX | TEVA PHARMACEUTICALS USA INC | 2bcdb81b97d479147d89a41feabbcbae7d67b1fad7e4ce57c6edb1b74f2f0eee |
| 458 | N | 208232 | 001 | OCTREOTIDE ACETATE | CAPSULE, DELAYED RELEASE;ORAL | CAPSULE, DELAYED RELEASE | ORAL | MYCAPSSA | CHIASMA | EQ 20MG BASE | | [] | 2020-06-26 | Jun 26, 2020 | No | Yes | Yes | RX | CHIASMA INC | 6b900adbeb489d2dfdd33970eb2b6936174f56fccd52d495c5aa476449628dcc |
| 459 | N | 204655 | 001 | ESOMEPRAZOLE MAGNESIUM | CAPSULE, DELAYED RELEASE;ORAL | CAPSULE, DELAYED RELEASE | ORAL | NEXIUM 24HR | ASTRAZENECA LP | EQ 20MG BASE | | [] | 2014-03-28 | Mar 28, 2014 | No | Yes | Yes | OTC | ASTRAZENECA LP | 853afbd00566b6e7927f5c49aa3da69605aa02ddb17ca4969c40ddd05d077f20 |
| 460 | A | 078878 | 001 | OMEPRAZOLE MAGNESIUM | CAPSULE, DELAYED RELEASE;ORAL | CAPSULE, DELAYED RELEASE | ORAL | OMEPRAZOLE MAGNESIUM | DR REDDYS LABS LTD | EQ 20MG BASE | | [] | 2009-06-05 | Jun 5, 2009 | No | No | Yes | OTC | DR REDDYS LABORATORIES LTD | feb29f8811de1088ddde329606741ba30be3b16e811269a9b151f86186a927b2 |
| 461 | A | 210593 | 001 | OMEPRAZOLE MAGNESIUM | CAPSULE, DELAYED RELEASE;ORAL | CAPSULE, DELAYED RELEASE | ORAL | OMEPRAZOLE MAGNESIUM | SPIL | EQ 20MG BASE | | [] | 2018-07-20 | Jul 20, 2018 | No | No | No | OTC | SUN PHARMA INDUSTRIES LTD | c086ff63b909add116f4f27622ddf41ca855717ddcd24252fd33158ff54aa396 |
| 462 | N | 203389 | 001 | CYSTEAMINE BITARTRATE | CAPSULE, DELAYED RELEASE;ORAL | CAPSULE, DELAYED RELEASE | ORAL | PROCYSBI | HORIZON PHARMA USA | EQ 25MG BASE | | [] | 2013-04-30 | Apr 30, 2013 | No | Yes | No | RX | HORIZON PHARMA USA INC | 548d7ee6be1f221ab0a333aadac4b8b7836c053883bed8158896e744e8969503 |
| 463 | N | 203389 | 002 | CYSTEAMINE BITARTRATE | CAPSULE, DELAYED RELEASE;ORAL | CAPSULE, DELAYED RELEASE | ORAL | PROCYSBI | HORIZON PHARMA USA | EQ 75MG BASE | | [] | 2013-04-30 | Apr 30, 2013 | No | Yes | Yes | RX | HORIZON PHARMA USA INC | 05bffecf21b01e1ddb1d73459a0747c298622deedd6947f0b0a99b7351590382 |
| 464 | N | 022152 | 001 | VALPROIC ACID | CAPSULE, DELAYED RELEASE;ORAL | CAPSULE, DELAYED RELEASE | ORAL | STAVZOR | BIONPHARMA INC | 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | 2008-07-29 | Jul 29, 2008 | No | Yes | No | DISCN | BIONPHARMA INC | 0c7f97605830ac1306a482b41b6efb2cd4421f47749d65a47268860604982e93 |
| 465 | N | 022152 | 002 | VALPROIC ACID | CAPSULE, DELAYED RELEASE;ORAL | CAPSULE, DELAYED RELEASE | ORAL | STAVZOR | BIONPHARMA INC | 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | 2008-07-29 | Jul 29, 2008 | No | Yes | No | DISCN | BIONPHARMA INC | f2994a77a8bc52c1d3ec8868843037b0f2536d3ec5ad69390d2cfee712c2ff55 |
| 466 | N | 022152 | 003 | VALPROIC ACID | CAPSULE, DELAYED RELEASE;ORAL | CAPSULE, DELAYED RELEASE | ORAL | STAVZOR | BIONPHARMA INC | 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | 2008-07-29 | Jul 29, 2008 | No | Yes | No | DISCN | BIONPHARMA INC | 09d0fc7391c5b05a120a1a98e9ea93b5c461a923b2d26d808f7cc1dd3198c128 |
| 467 | N | 213004 | 001 | AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN | CAPSULE, DELAYED RELEASE;ORAL | CAPSULE, DELAYED RELEASE | ORAL | TALICIA | REDHILL | 250MG;EQ 10MG BASE;12.5MG | | [] | 2019-11-01 | Nov 1, 2019 | No | Yes | Yes | RX | REDHILL BIOPHARMA LTD | ba777017910497d6ec90ecd34a04968fff709e0262f874d283e75487474aed2f |
| 468 | N | 204063 | 001 | DIMETHYL FUMARATE | CAPSULE, DELAYED RELEASE;ORAL | CAPSULE, DELAYED RELEASE | ORAL | TECFIDERA | BIOGEN IDEC INC | 120MG | AB | ["AB"] | 2013-03-27 | Mar 27, 2013 | No | Yes | No | RX | BIOGEN IDEC INC | f9253b77a8ab7190165c6680061cab4a6f48e4d48a9d7d280806b29bd8e258c9 |
| 469 | N | 204063 | 002 | DIMETHYL FUMARATE | CAPSULE, DELAYED RELEASE;ORAL | CAPSULE, DELAYED RELEASE | ORAL | TECFIDERA | BIOGEN IDEC INC | 240MG | AB | ["AB"] | 2013-03-27 | Mar 27, 2013 | No | Yes | Yes | RX | BIOGEN IDEC INC | 688b9e4a14c001bf70d69cb635c264700fcee665658ac0e020a8f1a2dd74366a |
| 470 | N | 022224 | 001 | CHOLINE FENOFIBRATE | CAPSULE, DELAYED RELEASE;ORAL | CAPSULE, DELAYED RELEASE | ORAL | TRILIPIX | ABBVIE | EQ 45MG FENOFIBRIC ACID | AB | ["AB"] | 2008-12-15 | Dec 15, 2008 | No | Yes | No | RX | ABBVIE INC | 1ff050bf87f3b0277e9bbdc7aaf4065f866f2b2048f8e5a5421c0fb50dfad549 |
| 471 | N | 022224 | 002 | CHOLINE FENOFIBRATE | CAPSULE, DELAYED RELEASE;ORAL | CAPSULE, DELAYED RELEASE | ORAL | TRILIPIX | ABBVIE | EQ 135MG FENOFIBRIC ACID | AB | ["AB"] | 2008-12-15 | Dec 15, 2008 | No | Yes | Yes | RX | ABBVIE INC | ea2d57256647351ede4f7be76ef36dd01b80ea3364dff63a8f9188cbd0ac2d45 |
| 472 | N | 211855 | 001 | DIROXIMEL FUMARATE | CAPSULE, DELAYED RELEASE;ORAL | CAPSULE, DELAYED RELEASE | ORAL | VUMERITY | BIOGEN | 231MG | | [] | 2019-10-29 | Oct 29, 2019 | No | Yes | Yes | RX | BIOGEN | a0a841d72dc29dd058e8a299aded300aea7598b6e7c9e9fd3c3be8338a92bf79 |
| 473 | A | 207659 | 001 | ACETAZOLAMIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | ACETAZOLAMIDE | ACCORD HLTHCARE | 500MG | | [] | 2018-10-18 | Oct 18, 2018 | No | No | No | DISCN | ACCORD HEALTHCARE INC | 28ad435b88b96f4c49aa3edd7dd5535611b833924aaf99e9b55b74424b76b927 |
| 474 | A | 210423 | 001 | ACETAZOLAMIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | ACETAZOLAMIDE | ALEMBIC PHARMS LTD | 500MG | AB | ["AB"] | 2019-02-19 | Feb 19, 2019 | No | No | No | RX | ALEMBIC PHARMACEUTICALS LTD | 7e10ce0a7204bfd4fc28437f65fd5ba3a8e6f14218333a4243128d2cda78435b |
| 475 | A | 205301 | 001 | ACETAZOLAMIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | ACETAZOLAMIDE | CADILA | 500MG | AB | ["AB"] | 2019-01-16 | Jan 16, 2019 | No | No | No | RX | CADILA HEALTHCARE LTD | e170331d50578466ded1afc9e9fc7b05ab64b79a2a3efc2cc882675ca8e6eab0 |
| 476 | A | 040904 | 001 | ACETAZOLAMIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | ACETAZOLAMIDE | HERITAGE PHARMA | 500MG | AB | ["AB"] | 2008-12-10 | Dec 10, 2008 | No | No | No | RX | HERITAGE PHARMA LABS INC | 4b24dc56af9aab91071e3b1c8f061b3fa817282194f1921150142f167caed63d |
| 477 | A | 090779 | 001 | ACETAZOLAMIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | ACETAZOLAMIDE | HERITAGE PHARMS INC | 500MG | AB | ["AB"] | 2011-07-14 | Jul 14, 2011 | No | No | Yes | RX | HERITAGE PHARMACEUTICALS INC | e4b6cf44b13da565f901d5b1e682143f313bf702dc74d34cfcfb6ed4c260f527 |
| 478 | A | 207401 | 001 | ACETAZOLAMIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | ACETAZOLAMIDE | MICRO LABS LTD INDIA | 500MG | AB | ["AB"] | 2020-10-01 | Oct 1, 2020 | No | No | No | RX | MICRO LABS LTD INDIA | a0f23a21b212d40b52a202b044eafde05e26546fc85bdc145a36e1505804ffa7 |
| 479 | A | 203917 | 001 | ACETAZOLAMIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | ACETAZOLAMIDE | MYLAN | 500MG | | [] | 2019-06-18 | Jun 18, 2019 | No | No | No | DISCN | MYLAN PHARMACEUTICALS INC | 2b041d745a2cb2edde8be2dfb77c6e743873c4df0a52c5339ed3c8c806583750 |
| 480 | A | 204691 | 001 | ACETAZOLAMIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | ACETAZOLAMIDE | NOSTRUM LABS INC | 500MG | AB | ["AB"] | 2016-03-29 | Mar 29, 2016 | No | No | No | RX | NOSTRUM LABORATORIES INC | 978971c71bb951f4f77a99a7cbdfae310762f3e43b96b43f023edc6cd9f0ad15 |
| 481 | A | 203434 | 001 | ACETAZOLAMIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | ACETAZOLAMIDE | NOVAST LABS | 500MG | AB | ["AB"] | 2016-09-30 | Sep 30, 2016 | No | No | No | RX | NOVAST LABORATORIES LTD | 6c2f544083fb15045a0cfc99353241e856483c092c7b1c0236912b9219633584 |
| 482 | N | 018996 | 001 | PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | ACTIFED | GLAXOSMITHKLINE | 120MG;5MG | | [] | 1985-06-17 | Jun 17, 1985 | No | No | No | DISCN | GLAXOSMITHKLINE | e9b0d960f5e278dd199c260b65aca127dca1811937de6bbc51a84870429adf84 |
| 483 | N | 021303 | 001 | AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | ADDERALL XR 10 | TAKEDA PHARMS USA | 2.5MG;2.5MG;2.5MG;2.5MG | AB | ["AB"] | 2001-10-11 | Oct 11, 2001 | No | Yes | No | RX | TAKEDA PHARMACEUTICALS USA INC | c5f2dce02d22ed3b8c575e7694ec6a642947907c883c18eba381ce137383f0d8 |
| 484 | N | 021303 | 006 | AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | ADDERALL XR 15 | TAKEDA PHARMS USA | 3.75MG;3.75MG;3.75MG;3.75MG | AB | ["AB"] | 2002-05-22 | May 22, 2002 | No | Yes | No | RX | TAKEDA PHARMACEUTICALS USA INC | 8cbc124a6df20da31ef5fac2e15576497fc5345539750db4813ac2b0ea9928c9 |
| 485 | N | 021303 | 002 | AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | ADDERALL XR 20 | TAKEDA PHARMS USA | 5MG;5MG;5MG;5MG | AB | ["AB"] | 2001-10-11 | Oct 11, 2001 | No | Yes | No | RX | TAKEDA PHARMACEUTICALS USA INC | 3922fa98b9d170ec56ef97f898682b933134d89adc9b41d0f875b228889e3f44 |
| 486 | N | 021303 | 004 | AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | ADDERALL XR 25 | TAKEDA PHARMS USA | 6.25MG;6.25MG;6.25MG;6.25MG | AB | ["AB"] | 2002-05-22 | May 22, 2002 | No | Yes | No | RX | TAKEDA PHARMACEUTICALS USA INC | a47cdbbf1c7c69b58e2f77f61706c9caa5314c03377b373f30245630dc49b03b |
| 487 | N | 021303 | 003 | AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | ADDERALL XR 30 | TAKEDA PHARMS USA | 7.5MG;7.5MG;7.5MG;7.5MG | AB | ["AB"] | 2001-10-11 | Oct 11, 2001 | No | Yes | Yes | RX | TAKEDA PHARMACEUTICALS USA INC | 4b27e805aa040b26738763c52d4b429ffe13642b34ad9ea876df0059e583948f |
| 488 | N | 021303 | 005 | AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | ADDERALL XR 5 | TAKEDA PHARMS USA | 1.25MG;1.25MG;1.25MG;1.25MG | AB | ["AB"] | 2002-05-22 | May 22, 2002 | No | Yes | No | RX | TAKEDA PHARMACEUTICALS USA INC | 7d82ac051f217e0abac72d5a349af930e9deef8173308acf6e90aa81fdcfcabe |
| 489 | N | 212038 | 001 | METHYLPHENIDATE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | ADHANSIA XR | PURDUE PHARMA LP | 25MG | | [] | 2019-02-27 | Feb 27, 2019 | No | Yes | No | RX | PURDUE PHARMA LP | 6bd18ea5f92e3ac760650423a42857ca95702affc7b6f9ede1c8c6158af25a8f |
| 490 | N | 212038 | 002 | METHYLPHENIDATE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | ADHANSIA XR | PURDUE PHARMA LP | 35MG | | [] | 2019-02-27 | Feb 27, 2019 | No | Yes | No | RX | PURDUE PHARMA LP | 448de6a1c6aeb6e9f11db2154fd1466e01d203be51aae1ef1828bf9812e8eff0 |
| 491 | N | 212038 | 003 | METHYLPHENIDATE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | ADHANSIA XR | PURDUE PHARMA LP | 45MG | | [] | 2019-02-27 | Feb 27, 2019 | No | Yes | No | RX | PURDUE PHARMA LP | 3dbab60c4a7e3736c6a7e55001eeeb2d07376150a17ceff89cd4e7f7bf1bc6af |
| 492 | N | 212038 | 004 | METHYLPHENIDATE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | ADHANSIA XR | PURDUE PHARMA LP | 55MG | | [] | 2019-02-27 | Feb 27, 2019 | No | Yes | No | RX | PURDUE PHARMA LP | d31b8d135f863779483522d02e60f092e4d0313ce3c60161c29ce3fa1e5045a7 |
| 493 | N | 212038 | 005 | METHYLPHENIDATE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | ADHANSIA XR | PURDUE PHARMA LP | 70MG | | [] | 2019-02-27 | Feb 27, 2019 | No | Yes | No | RX | PURDUE PHARMA LP | 43dcc5e7828d8c59d3ee82f1a4059c02cf939b316767245d8f0c28d73abf2d75 |
| 494 | N | 212038 | 006 | METHYLPHENIDATE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | ADHANSIA XR | PURDUE PHARMA LP | 85MG | | [] | 2019-02-27 | Feb 27, 2019 | No | Yes | Yes | RX | PURDUE PHARMA LP | aae10304f070100cea66e947ad3a7b8b16a0d269956a310065a7b3dd0e4e50b9 |
| 495 | A | 085075 | 003 | THEOPHYLLINE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | AEROLATE III | FLEMING PHARMS | 65MG | | [] | 1986-11-24 | Nov 24, 1986 | No | No | No | DISCN | FLEMING AND CO PHARMACEUTICALS INC | ca5939ab6d4d8ef6ee62d1bed2cf6fa9e7b478a0477ea80a3a6948fe1fe8889b |
| 496 | A | 085075 | 002 | THEOPHYLLINE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | AEROLATE JR | FLEMING PHARMS | 130MG | | [] | 1986-11-24 | Nov 24, 1986 | No | No | No | DISCN | FLEMING AND CO PHARMACEUTICALS INC | 38f3f52d4059973641e8e878716fdd4234dccc1a4252d88fa567f8ab1670ce08 |
| 497 | A | 085075 | 001 | THEOPHYLLINE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | AEROLATE SR | FLEMING PHARMS | 260MG | | [] | 1986-11-24 | Nov 24, 1986 | No | No | No | DISCN | FLEMING AND CO PHARMACEUTICALS INC | 1f3515782b2dcd38156890ba64d78c5d7e1be1a915d76e22b0fdbca15ffe0170 |
| 498 | N | 020884 | 001 | ASPIRIN; DIPYRIDAMOLE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | AGGRENOX | BOEHRINGER INGELHEIM | 25MG;200MG | AB | ["AB"] | 1999-11-22 | Nov 22, 1999 | No | Yes | Yes | RX | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | ae2298dbb9eeb87009069629c99524c9d42acc4cf641b384f1f205d4bfb82cfc |
| 499 | N | 021777 | 001 | CYCLOBENZAPRINE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | AMRIX | TEVA PHARMS INTL | 15MG | AB | ["AB"] | 2007-02-01 | Feb 1, 2007 | No | Yes | No | RX | TEVA PHARMACEUTICALS INTERNATIONAL GMBH | 8efa1d89eecd8b17dc4e4ca170170eff5680688088d6210dab200328286c6ca7 |
| 500 | N | 021777 | 002 | CYCLOBENZAPRINE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | AMRIX | TEVA PHARMS INTL | 30MG | AB | ["AB"] | 2007-02-01 | Feb 1, 2007 | No | Yes | Yes | RX | TEVA PHARMACEUTICALS INTERNATIONAL GMBH | dc844c8e9ead90bbd1630cae8075b652f5177ea3d1184b5442757911d3d7e386 |
| 501 | N | 022301 | 001 | MESALAMINE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | APRISO | VALEANT PHARMS INTL | 375MG | AB | ["AB"] | 2008-10-31 | Oct 31, 2008 | No | Yes | Yes | RX | VALEANT PHARMACEUTICALS INTERNATIONAL | 5be0a3c7f4a5d128d0d959a1a83c6b3ff68b0139156b45c078140d7edc0cac0b |